Literature DB >> 12651945

Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites.

Niklas Lindgren1, Alessandro Usiello, Michel Goiny, John Haycock, Eric Erbs, Paul Greengard, Tomas Hokfelt, Emiliana Borrelli, Gilberto Fisone.   

Abstract

Dopamine D2 receptors are highly expressed in the dorsal striatum where they participate in the regulation of (i) tyrosine hydroxylase (TH), in nigrostriatal nerve terminals, and (ii) the dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32), in medium spiny neurons. Two isoforms of the D2 receptor are generated by differential splicing of the same gene and are referred to as short (D2S) and long (D2L) dopamine receptors. Here we have used wild-type mice, dopamine D2 receptor knockout mice (D2 KO mice; lacking both D2S and D2L receptors) and D2L receptor-selective knockout mice (D2L KO mice) to evaluate the involvement of each isoform in the regulation of the phosphorylation of TH and DARPP-32. Incubation of striatal slices from wild-type mice with quinpirole, a dopamine D2 receptor agonist, decreased the state of phosphorylation of TH at Ser-40 and its enzymatic activity. Both effects were abolished in D2 KO mice but were still present in D2L KO mice. In wild-type mice, quinpirole inhibits the increase in DARPP-32 phosphorylation at Thr-34 induced by SKF81297, a dopamine D1 receptor agonist. This effect is absent in D2 KO as well as D2L KO mice. The inability of quinpirole to regulate DARPP-32 phosphorylation in D2L KO mice cannot be attributed to decreased coupling of D2S receptors to G proteins, because quinpirole produces a similar stimulation of [(35)S]GTPgammaS binding in wild-type and D2L KO mice. These results demonstrate that D2S and D2L receptors participate in presynaptic and postsynaptic dopaminergic transmission, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12651945      PMCID: PMC153088          DOI: 10.1073/pnas.0730708100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms.

Authors:  M Lindskog; P Svenningsson; B B Fredholm; P Greengard; G Fisone
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

Review 2.  Dopamine D2 receptors in signal transduction and behavior.

Authors:  R Picetti; A Saiardi; T Abdel Samad; Y Bozzi; J H Baik; E Borrelli
Journal:  Crit Rev Neurobiol       Date:  1997

3.  DARPP-32: regulator of the efficacy of dopaminergic neurotransmission.

Authors:  A A Fienberg; N Hiroi; P G Mermelstein; W Song; G L Snyder; A Nishi; A Cheramy; J P O'Callaghan; D B Miller; D G Cole; R Corbett; C N Haile; D C Cooper; S P Onn; A A Grace; C C Ouimet; F J White; S E Hyman; D J Surmeier; J Girault; E J Nestler; P Greengard
Journal:  Science       Date:  1998-08-07       Impact factor: 47.728

4.  Prominence of the dopamine D2 short isoform in dopaminergic pathways.

Authors:  Z U Khan; L Mrzljak; A Gutierrez; A de la Calle; P S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

5.  Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons.

Authors:  P Svenningsson; M Lindskog; F Rognoni; B B Fredholm; P Greengard; G Fisone
Journal:  Neuroscience       Date:  1998-05       Impact factor: 3.590

6.  Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice.

Authors:  M L'hirondel; A Chéramy; G Godeheu; F Artaud; A Saiardi; E Borrelli; J Glowinski
Journal:  Brain Res       Date:  1998-05-11       Impact factor: 3.252

Review 7.  Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice.

Authors:  T E Koeltzow; M Xu; D C Cooper; X T Hu; S Tonegawa; M E Wolf; F J White
Journal:  J Neurosci       Date:  1998-03-15       Impact factor: 6.167

8.  Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations.

Authors:  M A Kelly; M Rubinstein; T J Phillips; C N Lessov; S Burkhart-Kasch; G Zhang; J R Bunzow; Y Fang; G A Gerhardt; D K Grandy; M J Low
Journal:  J Neurosci       Date:  1998-05-01       Impact factor: 6.167

9.  Bidirectional regulation of DARPP-32 phosphorylation by dopamine.

Authors:  A Nishi; G L Snyder; P Greengard
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

10.  Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice.

Authors:  M A Kelly; M Rubinstein; S L Asa; G Zhang; C Saez; J R Bunzow; R G Allen; R Hnasko; N Ben-Jonathan; D K Grandy; M J Low
Journal:  Neuron       Date:  1997-07       Impact factor: 17.173

View more
  67 in total

Review 1.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

2.  Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization.

Authors:  Beryl Koener; Stéphanie Goursaud; Morgane Van De Stadt; André-Guilhem Calas; Anne P Jeanjean; Jean-Marie Maloteaux; Emmanuel Hermans
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01       Impact factor: 3.000

3.  Drosophila Dopamine2-like receptors function as autoreceptors.

Authors:  Trisha L Vickrey; B Jill Venton
Journal:  ACS Chem Neurosci       Date:  2011-12-21       Impact factor: 4.418

4.  Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine.

Authors:  Francesco Napolitano; Alessandra Bonito-Oliva; Mauro Federici; Manolo Carta; Francesco Errico; Salvatore Magara; Giuseppina Martella; Robert Nisticò; Diego Centonze; Antonio Pisani; Howard H Gu; Nicola B Mercuri; Alessandro Usiello
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

5.  Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain.

Authors:  S S Kaalund; E N Newburn; T Ye; R Tao; C Li; A Deep-Soboslay; M M Herman; T M Hyde; D R Weinberger; B K Lipska; J E Kleinman
Journal:  Mol Psychiatry       Date:  2013-12-10       Impact factor: 15.992

6.  The Balance of PI3K and ERK Signaling Is Dysregulated in Prolactinoma and Modulated by Dopamine.

Authors:  Allyson K Roof; Siwanon Jirawatnotai; Tammy Trudeau; Crystal Kuzyk; Margaret E Wierman; Hiroaki Kiyokawa; Arthur Gutierrez-Hartmann
Journal:  Endocrinology       Date:  2018-06-01       Impact factor: 4.736

7.  Modulation by chronic antipsychotic administration of PKA- and GSK3β-mediated pathways and the NMDA receptor in rat ventral midbrain.

Authors:  Bo Pan; Chao Deng
Journal:  Psychopharmacology (Berl)       Date:  2019-05-03       Impact factor: 4.530

8.  Dopamine D2L Receptor Deficiency Causes Stress Vulnerability through 5-HT1A Receptor Dysfunction in Serotonergic Neurons.

Authors:  Norifumi Shioda; Yoshiki Imai; Yasushi Yabuki; Wataru Sugimoto; Kouya Yamaguchi; Yanyan Wang; Takatoshi Hikida; Toshikuni Sasaoka; Michihiro Mieda; Kohji Fukunaga
Journal:  J Neurosci       Date:  2019-08-01       Impact factor: 6.167

9.  Postnatal manganese exposure does not alter dopamine autoreceptor sensitivity in adult and adolescent male rats.

Authors:  Sanders A McDougall; Alena Mohd-Yusof; Graham J Kaplan; Zuhair I Abdulla; Ryan J Lee; Cynthia A Crawford
Journal:  Eur J Pharmacol       Date:  2013-02-28       Impact factor: 4.432

Review 10.  The role of D2-autoreceptors in regulating dopamine neuron activity and transmission.

Authors:  C P Ford
Journal:  Neuroscience       Date:  2014-01-23       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.